Skip to main content

Efficacy of perfusion CT in differentiating of pancreatic ductal adenocarcinoma from mass-forming chronic pancreatitis and characterization of isoattenuating pancreatic lesions



Multidetector computed tomography (MDCT) is routinely used in the diagnosis of pancreatic ductal adenocarcinoma (PDAC), but it may be inadequate in some cases, especially mass-forming chronic pancreatitis (MFCP) and isoattenuating pancreatic lesions. Perfusion CT (pCT) may help resolve this problem. The aim of this study was to evaluate whether pCT could help differentiating PDAC from MFCP and in characterization of isoattenuating pancreatic lesions.

Materials and methods

This prospective study included 89 cases of pancreatic lesions detected by MDCT and further analyzed with pCT. Sixty-one cases with final pathological diagnosis PDAC and 12 cases with MFCP were included from the study. Blood volume (BV), blood flow (BF), mean transit time (MTT), and permeability surface area product (PS) maps were obtained. Perfusion values obtained from the lesions and normal parenchyma were compared.


Compared with normal parenchyma, BV, BF, PS were lower and MTT was longer in PDAC and MFCP (p < 0.05). Compared with MFCP, BV, BF, PS were lower and MTT was longer in PDAC (p < 0.001). Compared with normal parenchyma, BV, BF, PS were lower and MTT was longer in isoattenuating lesions, (p < 0.001). Cutoff values of 7.60 mL/100 mL, 64.43 mL/100 mL/min, 28.08 mL/100 mL/min for BV, BF, PS, respectively, provided 100% sensitivity and specificity and 7.47 s for MTT provided 98.3% sensitivity, 80% specificity for distinguishing PDAC from MFCP.


pCT is a useful technology that can be helpful in overcoming the limitations of routine MDCT in diagnosing PDAC and characterization of isoattenuating lesions.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6


  1. Rahib L, Smith BD, Aizenberg R, et al. (2014) Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res 74:2913–2921

    Article  PubMed  CAS  Google Scholar 

  2. Klauss M, Stiller W, Pahn G, et al. (2013) Dual-energy perfusion-CT of pancreatic adenocarcinoma. Eur J Radiol 82:208–214

    Article  PubMed  CAS  Google Scholar 

  3. Kim R, Saif MW (2007) Is there an optimal neoadjuvant therapy for locally advanced pancreatic cancer? JOP 8:279–288

    PubMed  Google Scholar 

  4. Grözinger G, Grözinger A, Horger M (2014) The role of volume perfusion CT in the diagnosis of pathologies of the pancreas. Fortschr Röntgenstr 186:1082–1093

    Article  Google Scholar 

  5. Prokesch RW, Chow LC, Beaulieu CF, Bammer R, Jeffrey RB (2002) Isoattenuating pancreatic adenocarcinoma at multi–detector row CT: secondary signs. Radiology 224:764–768

    Article  PubMed  Google Scholar 

  6. Kim JH, Park SH, Yu ES, et al. (2010) Visually isoattenuating pancreatic adenocarcinoma at dynamic-enhanced CT: frequency, clinical and pathologic characteristics, and diagnosis at imaging examinations. Radiology 257:87–96

    Article  PubMed  Google Scholar 

  7. Yadav AK, Sharma R, Kandasamy D, et al. (2016) Perfusion CT–can it resolve the pancreatic carcinoma versus mass forming chronic pancreatitis conundrum? Pancreatology 16:979–987

    Article  PubMed  Google Scholar 

  8. Sahani DV, Kalva SP, Farrell J, et al. (2004) Autoimmune pancreatitis: imaging features. Radiology 233:345–352

    Article  PubMed  Google Scholar 

  9. Chang WI, Kim BJ, Lee JK, et al. (2009) The clinical and radiological characteristics of focal mass-forming autoimmune pancreatitis: comparison with chronic pancreatitis and pancreatic cancer. Pancreas 38:401–408

    Article  PubMed  Google Scholar 

  10. Ichikawa T, Sou H, Araki T, et al. (2001) Duct-penetrating sign at MRCP: usefulness for differentiating inflammatory pancreatic mass from pancreatic carcinomas. Radiology 221:107–116

    Article  PubMed  CAS  Google Scholar 

  11. Hartwig W, Schneider L, Diener MK, et al. (2009) Preoperative tissue diagnosis for tumours of the pancreas. Br J Surg 96:5–20

    Article  PubMed  CAS  Google Scholar 

  12. Kandel S, Kloeters C, Meyer H, et al. (2009) Whole-organ perfusion of the pancreas using dynamic volume CT in patients with primary pancreas carcinoma: acquisition technique, post-processing and initial results. Eur Radiol 19:2641–2646

    Article  PubMed  Google Scholar 

  13. Miles KA, Charnsangavej C, Lee FT, et al. (2000) Application of CT in the investigation of angiogenesis in oncology. Acad Radiol 7:840–850

    Article  PubMed  CAS  Google Scholar 

  14. Lu N, Feng XY, Hao SJ, et al. (2011) 64-slice CT perfusion imaging of pancreatic adenocarcinoma and mass-forming chronic pancreatitis. Acad Radiol 18:81–88

    Article  PubMed  Google Scholar 

  15. Xu J, Liang Z, Hao S, et al. (2009) Pancreatic adenocarcinoma: dynamic 64-slice helical CT with perfusion imaging. Abdom Imaging 34:759–766

    Article  PubMed  Google Scholar 

  16. Delrue L, Blanckaert P, Mertens D, et al. (2011) Assessment of tumor vascularization in pancreatic adenocarcinoma using 128-slice perfusion computed tomography imaging. J Comput Assist Tomogr 35:434–438

    Article  PubMed  Google Scholar 

  17. Klauss M, Stiller W, Fritz F, et al. (2012) Computed tomography perfusion analysis of pancreatic carcinoma. J Comput Assist Tomogr 36:237–242

    Article  PubMed  Google Scholar 

  18. Bluemke DA, Cameron JL, Hruban RH, et al. (1995) Potentially resectable pancreatic adenocarcinoma: spiral CT assessment with surgical and pathologic correlation. Radiology 197:381–385

    Article  PubMed  CAS  Google Scholar 

  19. Eastwood JD, Lev MH, Provenzale JM (2003) Perfusion CT with iodinated contrast material. AJR 180:3–12

    Article  PubMed  Google Scholar 

  20. Zhao X, Zhou C, Wu N, et al. (2003) Study of multiple slices pancreatic CT perfusion. Chin J Radiol 37:845–849

    Google Scholar 

  21. Kudo K, Sasaki M, Yamada K, et al. (2009) Differences in CT perfusion maps generated by different commercial software: quantitative analysis by using identical source data of acute stroke patients. Radiology 254:200–209

    Article  Google Scholar 

  22. van Kouwen MC, Jansen JB, van Goor H, et al. (2005) FDG-PET is able to detect pancreatic carcinoma in chronic pancreatitis. Eur J Nucl Med Mol Imaging 32:399–404

    Article  PubMed  Google Scholar 

  23. Keogan MT, Tyler D, Clark L, et al. (1998) Diagnosis of pancreatic carcinoma: role of FDG PET. AJR 171:1565–1570

    Article  PubMed  CAS  Google Scholar 

  24. Ruan Z, Jiao J, Min D, et al. (2018) Multimodality imaging features distinguish pancreatic carcinoma from mass-forming chronic pancreatitis of the pancreatic head. Oncol Lett 15:9735–9744

    PubMed  PubMed Central  Google Scholar 

  25. Delbeke D, Pinson CW (2004) Pancreatic tumors: role of imaging in the diagnosis, staging, and treatment. J Hepatobil Pancreat Surg 11:4–10

    Article  Google Scholar 

  26. Kato K, Nihashi T, Ikeda M, et al. (2013) Limited efficacy of 18F-FDG PET/CT for differentiation between metastasis-free pancreatic cancer and mass-forming chronic pancreatitis. Clin Nucl Med 38:417–421

    Article  PubMed  Google Scholar 

  27. Ozaki Y, Oguchi K, Hamano H, et al. (2008) Differentiation of autoimmune pancreatitis from suspected pancreatic cancer by fluorine-18 fluorodeoxyglucose positron emission tomography. J Gastroenterol 43:144–151

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Serdar Aslan.

Ethics declarations


No funding was received for this study.

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. For this type of study formal consent is not required.

Rights and permissions

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Aslan, S., Nural, M.S., Camlidag, I. et al. Efficacy of perfusion CT in differentiating of pancreatic ductal adenocarcinoma from mass-forming chronic pancreatitis and characterization of isoattenuating pancreatic lesions. Abdom Radiol 44, 593–603 (2019).

Download citation

  • Published:

  • Issue Date:

  • DOI: